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Background and Objective: Novel TB vaccines that aim to boost and/or replace Bacillus Calmette-Guerin (BCG) are currently in development. DNA vaccines can stimulate both
humoral and cell-mediated immunity in different animal models of TB and is thought to be a promising strategy in the development of new vaccines against TB. The aim of this study was
to design and construct a DNA vaccine encoding ag85a and tb10.4 fusion genes of Mycobacterium tuberculosis
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Materials and Methods: tb10.4 fragment was amplified by PCR and the products were digested with restriction enzymes. Next, it was cloned into the pcDNA3.1+ plasmid. The ag85a gene
and pcDNA3.1+/tb10.4 plasmid were digested by EcoRI and BamHI restriction enzymes. Constructed vector was sequenced and molecular analysis was done by using bioiinformatic software
such as DNAMAN. New chimeric vector containing Ag85a-tb10.4 genes were purified and for confirming expression of pcDNA3.1+/tb10.4-ag85a plasmid in eukaryotic cells ,Huh7.5 cell
lines were transfected with this recombinant vector.
Results: Using electrophoresis of PCR products, fragments 297 bp for tb10.4 and 1017 bp for ag85a were observed.alignment of ag85a-tb10.4 genom sequence with reference genes in
GenBank showed exact identity that indicate correction of aii cloning procedures. Eukaryotic cells transfection with pcDNA3.1+/tb10.4-ag85a vector was confirmed with cDNA synthesis and
existence of tb10.4-ag85a fusion gene was confirmed with RT-PCR(Fig1,2,3,4).
Conclusion:
In this study, tb10.4 and ag85a genes were isolated from Mycobacterium tuberculosis H37Rv strain and cloned into pcDNA3.1+ also in this study capability of constructed vector in
producing fusion Ag85a-tb10.4 protein was confirmed with RT-PCR. pcDNA3.1+/tb10.4-ag85a vector can be used for further studies in future.
Fig.1: Purified PCR product of tb10.4 gene on 
1.5% gel : Lane 1: 290 bp band of tb10.4 , Lane 
2: 1kb DNA size marker (SM0313, Fermentas, 
Germany)
Figure 2: Purified PCR product of ag85a gene on 
1.5% gel : Lane 1: 1017 bp band of ag85a , Lane 2: 
1kb DNA size marker (SM0313, Fermentas, 
Germany)
Fig 3: Restriction enzyme digestion of 
pcDNA3.1+/ag85a-tb10.4. Lane 1: 1kb DNA size 
marker (SM0313, Fermentas, Germany). Lane 2: 
1300 bp band of tb10.4/ag85a.
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Fig4: RT-PCR results. Lane 1: 1300 bp band of ag85a/tb10.4.Lane 2: 
1kb DNA size marker (SM0313, Fermentas, Germany).
